BrainsWay Ltd. (BWAY)
BWAY Stock Price Chart
Explore BrainsWay Ltd. interactive price chart. Choose custom timeframes to analyze BWAY price movements and trends.
BWAY Company Profile
Discover essential business fundamentals and corporate details for BrainsWay Ltd. (BWAY) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
17 Apr 2019
Employees
120.00
Website
https://www.brainsway.comCEO
Hadar Levy
Description
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
BWAY Financial Timeline
Browse a chronological timeline of BrainsWay Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is $0.10, while revenue estimate is $16.50m.
Earnings released on 13 May 2026
EPS came in at $0.12 surpassing the estimated $0.05 by +140.00%, while revenue for the quarter reached $15.53m , beating expectations by +6.13%.
Earnings released on 11 Mar 2026
EPS came in at $0.14 surpassing the estimated $0.06 by +133.33%, while revenue for the quarter reached $14.55m , beating expectations by +3.77%.
Stock split effective on 4 Mar 2026
Shares were split 2 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Nov 2025
EPS came in at $0.08 falling short of the estimated $0.11 by -27.27%, while revenue for the quarter reached $13.51m , missing expectations by -3.61%.
Earnings released on 30 Sept 2025
EPS came in at $0.05 , while revenue for the quarter reached $12.63m .
Earnings released on 13 May 2025
EPS came in at $0.04 surpassing the estimated $0.02 by +100.00%, while revenue for the quarter reached $11.54m , missing expectations by -5.18%.
Earnings released on 11 Mar 2025
EPS came in at $0.08 surpassing the estimated $0.05 by +60.00%, while revenue for the quarter reached $11.41m , missing expectations by -0.88%.
Earnings released on 12 Nov 2024
EPS came in at $0.04 surpassing the estimated $0.01 by +207.69%, while revenue for the quarter reached $10.50m , missing expectations by -3.27%.
Earnings released on 6 Aug 2024
EPS came in at $0.04 surpassing the estimated $0.02 by +100.00%, while revenue for the quarter reached $10.01m , missing expectations by -0.15%.
Earnings released on 8 May 2024
EPS came in at $0.01 surpassing the estimated $0.01 by +100.00%, while revenue for the quarter reached $9.10m , beating expectations by +4.30%.
Earnings released on 6 Mar 2024
EPS came in at $0.01 surpassing the estimated $0.01 by +100.00%, while revenue for the quarter reached $9.03m , beating expectations by +4.40%.
Earnings released on 15 Nov 2023
EPS came in at -$0.01 surpassing the estimated -$0.07 by +85.71%, while revenue for the quarter reached $8.30m , beating expectations by +7.22%.
Earnings released on 9 Aug 2023
EPS came in at -$0.10 surpassing the estimated -$0.17 by +41.18%, while revenue for the quarter reached $7.83m , beating expectations by +10.55%.
Earnings released on 17 May 2023
EPS came in at -$0.14 falling short of the estimated -$0.12 by -16.67%, while revenue for the quarter reached $6.63m , beating expectations by +3.52%.
Earnings released on 15 Mar 2023
EPS came in at -$0.24 falling short of the estimated -$0.12 by -100.00%, while revenue for the quarter reached $6.03m , missing expectations by -4.24%.
Earnings released on 16 Nov 2022
EPS came in at -$0.30 falling short of the estimated -$0.07 by -328.57%, while revenue for the quarter reached $5.17m , missing expectations by -38.84%.
Earnings released on 10 Aug 2022
EPS came in at -$0.14 falling short of the estimated -$0.08 by -75.00%, while revenue for the quarter reached $8.01m , missing expectations by -4.87%.
Earnings released on 11 May 2022
EPS came in at -$0.12 falling short of the estimated -$0.09 by -33.33%, while revenue for the quarter reached $7.97m , beating expectations by +6.98%.
Earnings released on 9 Mar 2022
EPS came in at -$0.08 falling short of the estimated -$0.05 by -60.00%, while revenue for the quarter reached $8.47m , beating expectations by +2.79%.
Earnings released on 17 Nov 2021
EPS came in at -$0.10 falling short of the estimated -$0.06 by -66.67%, while revenue for the quarter reached $8.06m , beating expectations by +22.69%.
Earnings released on 11 Aug 2021
EPS came in at -$0.12 falling short of the estimated -$0.07 by -71.43%, while revenue for the quarter reached $7.01m , beating expectations by +6.62%.
BWAY Stock Performance
Access detailed BWAY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
